Page last updated: 2024-10-22

alfuzosin and Asymmetric Septal Hypertrophy, Familial

alfuzosin has been researched along with Asymmetric Septal Hypertrophy, Familial in 1 studies

alfuzosin: structure given in first source

Research Excerpts

ExcerptRelevanceReference
" Incidents of adverse cardiac drug reactions are more common in patients with preexisting heart disease than the general population."1.39Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity. ( Bers, DM; Diecke, S; Gong, T; Knowles, JW; Lan, F; Lee, AS; Liang, P; Nguyen, PK; Robbins, RC; Sallam, K; Sanchez-Freire, V; Wang, PJ; Wang, Y; Wu, JC, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liang, P1
Lan, F1
Lee, AS1
Gong, T1
Sanchez-Freire, V1
Wang, Y1
Diecke, S1
Sallam, K1
Knowles, JW1
Wang, PJ1
Nguyen, PK1
Bers, DM1
Robbins, RC1
Wu, JC1

Other Studies

1 other study available for alfuzosin and Asymmetric Septal Hypertrophy, Familial

ArticleYear
Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.
    Circulation, 2013, Apr-23, Volume: 127, Issue:16

    Topics: Action Potentials; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic, Familial; Cell Differentia

2013